LMR Partners’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,145
| Closed | -$322K | – | 907 |
|
|
2024
Q4 | $322K | Hold |
23,145
| – | – | ﹤0.01% | 516 |
|
|
2024
Q3 | $215K | Hold |
23,145
| – | – | ﹤0.01% | 508 |
|
|
2024
Q2 | $215K | Hold |
23,145
| – | – | ﹤0.01% | 457 |
|
|
2024
Q1 | $229K | Hold |
23,145
| – | – | ﹤0.01% | 436 |
|
|
2023
Q4 | $74.8K | Hold |
23,145
| – | – | ﹤0.01% | 457 |
|
|
2023
Q3 | $123K | Sell |
23,145
-15,000
| -39% | -$79.7K | ﹤0.01% | 464 |
|
|
2023
Q2 | $364K | Buy |
38,145
+15,000
| +65% | +$143K | ﹤0.01% | 415 |
|
|
2023
Q1 | $255K | Hold |
23,145
| – | – | ﹤0.01% | 810 |
|
|
2022
Q4 | $343K | Hold |
23,145
| – | – | 0.01% | 922 |
|
|
2022
Q3 | $442K | Hold |
23,145
| – | – | 0.01% | 890 |
|
|
2022
Q2 | $493K | Hold |
23,145
| – | – | 0.01% | 907 |
|
|
2022
Q1 | $446K | Hold |
23,145
| – | – | 0.01% | 1008 |
|
|
2021
Q4 | $480K | Hold |
23,145
| – | – | ﹤0.01% | 916 |
|
|
2021
Q3 | $553K | Buy |
+23,145
| New | +$553K | 0.01% | 757 |
|